Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesTET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDS)
Blood, 08/12/09
Kosmider O et al. – The results indicate that TET2 mutations observed in 20% of patients, irrespective of the WHO or FAB subtype, represent a molecular marker for good prognosis in MDS.
Related Articles
Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09
Relevance Score: 68%
Hematopoiesis-related microRNA expression in myelodysplastic syndromes
Leukemia and Lymphoma, 11/06/09
Relevance Score: 67%
Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09
Relevance Score: 66%
Accelerated cellular senescence in myelodysplastic syndrome
Experimental Hematology, 10/22/09
Relevance Score: 66%
Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
Blood, 10/09/09
Relevance Score: 66%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
British Journal of Cancer, 12/11/09
Relationship between topoisomerase 2A RNA expression and recurrence after adjuvant chemotherapy for breast cancer
Clinical Cancer Research, 12/11/09
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers
Journal of Clinical Oncology, 12/10/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
Bone Marrow Transplantation, 12/10/09
Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells
European Journal of Haematology, 12/10/09
Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival
European Journal of Haematology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor